[Risk of infection through use of selective  immunomodulating drugs for rheumatoid arthritis].

Harboe, Erna; Damås, Jan Kristian; Omdal, Roald; Frøland, Stig S; Sjursen, Haakon

[Risk of infection through use of selective immunomodulating drugs for rheumatoid arthritis]. / Infeksjonsrisiko ved bruk av selektivt immunmodulerende midler mot revmatoid artritt.

Harboe, Erna; Damås, Jan Kristian; Omdal, Roald; Frøland, Stig S; Sjursen, Haakon.

Affiliation

Harboe E; Infeksjonsseksjonen, Medisinsk divisjon, Stavanger universitetssjukehus, Norway. hare@sus.no

Tidsskr Nor Laegeforen ; 132(16): 1867-71, 2012 Sep 04.

Article in Nor | MEDLINE | ID: mdl-22986971

Subject(s)

Antibodies, Monoclonal, Murine-Derived/adverse effects; Arthritis, Rheumatoid/drug therapy; Immunosuppressive Agents/adverse effects; Infections/chemically induced; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Antibodies, Monoclonal, Murine-Derived/administration & dosage; Antirheumatic Agents/adverse effects; Arthritis, Rheumatoid/complications; Drug Therapy, Combination/adverse effects; Hepacivirus/physiology; Hepatitis B/etiology; Hepatitis B virus/physiology; Hepatitis C/etiology; Humans; Immunosuppressive Agents/administration & dosage; Risk Assessment; Risk Factors; Rituximab; Tuberculosis/chemically induced; Virus Activation/drug effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Tumor Necrosis Factor-alpha / Antibodies, Monoclonal, Murine-Derived / Immunosuppressive Agents / Infections Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: Nor Journal: Tidsskr Nor Laegeforen Year: 2012 Type: Article Affiliation country: Norway

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google